Cita APA

Mesía Nin, R., Rubió-Casadevall, J., Cirauqui Cirauqui, B., Martinez Trufero, J., Plana Serrahima, M., García Castaño, A., . . . Ortega, E. (2023). TTCC-2019-02: Real-world evidence of first-line cetuximab plus paclitaxel in recurrent or metastatic squamous cell carcinoma of the head and neck.

Citación estilo Chicago

Mesía Nin, Ricard, et al. TTCC-2019-02: Real-world Evidence of First-line Cetuximab Plus Paclitaxel in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck. 2023.

Cita MLA

Mesía Nin, Ricard, et al. TTCC-2019-02: Real-world Evidence of First-line Cetuximab Plus Paclitaxel in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck. 2023.